Author: Cyril Barabaltchouk
Ukrainian President Zelenskyy calls on Russia to agree to a ceasefire, reaffirming Ukraine’s dedication to diplomacy and peace with European support.Read More
From 50 football pitches worth of sunflowers, to the destruction of Marinka town in Ukraine – here are the images of the day chosen by the Sky News picture editors.Read More
The Girl Guides of Canada says it’s pausing all trips to the U.S. starting in September, with plans to choose alternative locations, amid restrictions by the Trump administration.Read More
Glaciers carved the deep valleys of Banff, eroded Ontario to deposit the fertile soils of the Prairies, and continue to change Earth’s surface. But how fast do glaciers sculpt the landscape?Read More
When Connor Daigle of Union, Maine attended a career event at the Maine Business School, he didn’t expect it would lead him to a top-tier internship and an award-winning team project. Daigle, who is double majoring in marketing and business information systems and security management, led his team to victory…Read More
STORY: Trump in a social media post called Tan, who was hired in March to turn around the struggling chipmaker, “highly conflicted” due to the Intel CEO’s ties to Chinese firms.Coons said that for Trump to say there is a conflict of interest “feels a little bit like the pot calling the kettle black.””There’s conflict all over the place,” Coons added. “We just have to be real about that.”A leadership change could pile pressure on Intel, which is a pillar of U.S. efforts to boost domestic chipmaking, after the chipmaker secured $8 billion in government subsidies to build new factories…
Reiterate top-line data readout from CBeyond™ Phase 2a study of nimacimab planned late Q3/early Q4 2025Patient enrollment in Skye’s CBeyondTM Phase 2a obesity trial extension study initiated Independent Data Safety Monitoring Committee completed fourth unblinded review with no concerns raised; CBeyondTM study continues per protocolNew preclinical study highlights superior weight rebound profile of nimacimab compared to incretin therapy.Preclinical data shows dosing nimacimab in combination withRead More
– May 12, 2025 announcement of positive interim data from ongoing Phase 1 study of CX-2051 (EpCAM Antibody Drug Conjugate) in patients with advanced colorectal cancer (CRC) – – CX-2051 Phase 1 dose expansions on track for data update in Q1 2026. Phase 2 study initiation in CRC anticipated 1H 2026 – – Combination dose escalation initiated of CX-801 masked interferon alpha-2b with KEYTRUDA® (pembrolizumab) in patients with advanced melanoma – – Completed $100 million underwritten offering of commoRead More
Notre Dame transfer Malachi Fields became one of 47 wide receivers in the NCAAF named to the Biletnikoff Award watch list.Read More
Here’s today’s Connections: Sports Edition answer and hints for groups. These clues will help you solve The New York Times’ popular puzzle game, Connections: Sports Edition, every day.Read More